SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-178843
Filing Date
2022-06-22
Accepted
2022-06-22 16:52:33
Documents
12
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 20-F d358835d20f.htm 20-F 232746
2 EX-1.1 d358835dex11.htm EX-1.1 116012
3 EX-2.5 d358835dex25.htm EX-2.5 1160576
4 EX-2.6 d358835dex26.htm EX-2.6 1152302
5 EX-2.7 d358835dex27.htm EX-2.7 57337
6 EX-4.38 d358835dex438.htm EX-4.38 34135
7 EX-4.39 d358835dex439.htm EX-4.39 167175
8 EX-15.1 d358835dex151.htm EX-15.1 239723
9 EX-15.2 d358835dex152.htm EX-15.2 1303
10 EX-15.3 d358835dex153.htm EX-15.3 1326
11 GRAPHIC g358835dsp18a.jpg GRAPHIC 4708
12 GRAPHIC g358835hc_18.jpg GRAPHIC 2244
  Complete submission text file 0001193125-22-178843.txt   3173583
Mailing Address 9, RUE DE BITBOURG LUXEMBOURG N4 L-1273
Business Address 9, RUE DE BITBOURG LUXEMBOURG N4 L-1273 354 422-4500
Alvotech (Filer) CIK: 0001898416 (see all company filings)

IRS No.: 981629342 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-41421 | Film No.: 221032632
SIC: 2836 Biological Products, (No Diagnostic Substances)